CSK INHIBITION OF C-SRC ACTIVITY REQUIRES BOTH THE SH2 AND SH3 DOMAINS OF SRC

被引:249
|
作者
SUPERTIFURGA, G [1 ]
FUMAGALLI, S [1 ]
KOEGL, M [1 ]
COURTNEIDGE, SA [1 ]
DRAETTA, G [1 ]
机构
[1] EUROPEAN MOLEC BIOL LAB, DIFFERENTIAT PROGRAMME, MEYERHOFSTR 1, W-6900 HEIDELBERG, GERMANY
来源
EMBO JOURNAL | 1993年 / 12卷 / 07期
关键词
CSK; SH2; DOMAIN; SH3; SRC; TYROSINE KINASE;
D O I
10.1002/j.1460-2075.1993.tb05923.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The protein tyrosine kinase c-Src is negatively regulated by phosphorylation of Tyr527 in its carboxy-terminal tail. A kinase that phosphorylates Tyr527, called Csk, has recently been identified. We expressed c-Src in yeast to test the role of the SH2 and SH3 domains of Src in the negative regulation exerted by Tyr527 phosphorylation. Inducible expression of c-Src in Schizosaccharomyces pombe caused cell death. Co-expression of Csk counteracted this effect. Src proteins mutated in either the SH2 or SH3 domain were as lethal as wild type c-Src, but were insensitive to Csk, even though they were substrates for Csk in vivo. Peptide binding experiments revealed that Src proteins with mutant SH3 domains adopted a conformation in which the SH2 domain was not interacting with the tail. These data support the model of an SH2 domain-phosphorylated tail interaction repressing c-Src activity, but expand it to include a role for the SH3 domain. We propose that the SH3 domain contributes to the maintenance of the folded, inactive configuration of the Src molecule by stabilizing the SH2 domain - phosphorylated tail interaction. Moreover, the system we describe here allows for further study of the regulation of tyrosine kinases in a neutral background and in an organism amenable to genetic analysis.
引用
收藏
页码:2625 / 2634
页数:10
相关论文
共 50 条
  • [11] Cooperative activation of Src family kinases by SH3 and SH2 ligands
    Yadav, Shalini S.
    Miller, W. Todd
    CANCER LETTERS, 2007, 257 (01) : 116 - 123
  • [12] Recent Progress of Src SH2 and SH3 Inhibitors as Anticancer Agents
    Lu, X. -L.
    Cao, X.
    Liu, X. -Y.
    Jiao, B. -H.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (12) : 1117 - 1124
  • [13] Ligand specificity switching in the c-Src SH2 domain
    Showalter, SA
    Young, JK
    Nicholson, LK
    BIOPHYSICAL JOURNAL, 1999, 76 (01) : A246 - A246
  • [14] STRUCTURES OF SH2 AND SH3 DOMAINS
    KURIYAN, J
    COWBURN, D
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 1993, 3 (06) : 828 - 837
  • [15] Functions of SH2 and SH3 domains
    Mayer, BJ
    Gupta, R
    PROTEIN MODULES IN SIGNAL TRANSDUCTION, 1998, 228 : 1 - 22
  • [16] AN RNA-BINDING PROTEIN ASSOCIATED WITH SRC THROUGH ITS SH2 AND SH3 DOMAINS IN MITOSIS
    TAYLOR, SJ
    SHALLOWAY, D
    NATURE, 1994, 368 (6474) : 867 - 871
  • [17] EGF Regulates the Interaction of Tks4 with Src through Its SH2 and SH3 Domains
    Dulk, Metta
    Szeder, Balint
    Glatz, Gabor
    Mero, Balazs L.
    Koprivanacz, Kitti
    Kudlik, Gyongyi
    Vas, Virag
    Sipeki, Szabolcs
    Cserkaszky, Anna
    Radnai, Laszlo
    Buday, Laszlo
    BIOCHEMISTRY, 2018, 57 (28) : 4186 - 4196
  • [18] Crystal structure of unphosphorylated C-SRC in complex with an analogue of Gleevec™ reveals relative orientations of the SH3, SH2 and kinase domains in the active conformation.
    Cowan-Jacob, SW
    Fendrich, G
    Liebetanz, J
    Fabbro, D
    Manley, PW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U434 - U435
  • [19] Lipid binding by the Unique and SH3 domains of c-Src suggests a new regulatory mechanism
    Perez, Yolanda
    Maffei, Mariano
    Igea, Ana
    Amata, Irene
    Gairi, Margarida
    Nebreda, Angel R.
    Bernado, Pau
    Pons, Miquel
    SCIENTIFIC REPORTS, 2013, 3
  • [20] Critical amino acid substitutions in the Src SH3 domain that convert c-Src to be oncogenic
    Miyazaki, K
    Senga, T
    Matsuda, S
    Tanaka, M
    Machida, K
    Takenouchi, Y
    Nimura, Y
    Hamaguchi, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 263 (03) : 759 - 764